--(BUSINESS WIRE)--UNH Board Authorizes Payment of Quarterly Dividend.
Investors looking for unusually high-yielding dividend stocks have a couple of interesting options these days. Shares of at least two well-established businesses have been beaten down by more than hal
Some pretty hard-hit value names were quite popular among the smart money in the second quarter.
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and anoth
UnitedHealth Group Incorporated is down 56% in a year — yet insiders and big funds are loading up. Q2 earnings disappointed, but new guidance and cost cuts could mark a turning point. My bearish val
UNH's valuation is now quite modest after severe earnings cuts and negative headlines, offering a good margin of safety for long-term investors. The worst appears priced in; 2025 will be rough, but a
BOSTON--(BUSINESS WIRE)-- #histologymatters--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic
NVIDIA, Microsoft, and Netflix were top contributors, driven by strong earnings, AI leadership, and robust subscriber/ad growth, reinforcing our long-term conviction in these names. UnitedHealth and A

UnitedHealth: Much Worse Than Expected

10:48am, Monday, 11'th Aug 2025
UNH's Q2 earnings revealed further weakness with margins at both insurance and Optum plunging to multi-year lows while sales continued to grow at double-digits. Reestablished outlook implies no recove
I reiterate my bullish rating on UNH, supported by strong membership growth and innovative cost-cutting strategies like AI efficiencies and private-label initiatives. UNH is prioritizing affordability
UnitedHealth (UNH -0.55%) stock is trading near its 52-week low.
UNH's Q2 was disastrous, with missed earnings, rising medical costs, and sharply lowered guidance, deepening market pessimism and uncertainty. Despite negative headlines, the stock's valuation is now
UNH plunges 12.9% after weak Q2 and slashing 2025 EPS guidance, sparking fears of deeper structural issues ahead.
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE